文献速递胸部神经CT

新诊断非小细胞肺癌脑转移预测因素的单中心队列研究

Identification of predictors for brain metastasis in newly diagnosed non-small cell lung cancer: a single-center cohort study.
PubMed 文献 · Eur Radiol · 2021-08-10

该单中心队列纳入911例新诊断NSCLC患者,按可切除性分层分析脑转移的临床与胸部CT预测因素。可切除期独立预测因素为N2期、无空气支气管征/空泡透亮影及有毛刺,联合影像特征模型AUC为0.723;不可切除期预测因素包括年轻、女性、胸外转移及腺癌,模型AUC为0.675-0.766。

要点

  • 可切除期NSCLC出现N2、无空气支气管征/空泡透亮影及毛刺时提示脑转移风险升高
  • 不可切除期脑转移预测因素包括年轻、女性、胸外转移及腺癌
  • 已知EGFR突变状态时,胸外转移和EGFR突变阳性为独立预测因素

核心结论

  • 胸部CT影像特征、临床分期、肺癌亚型及EGFR突变与NSCLC脑转移相关,且可切除与不可切除期的预测因素完全不同。

关键影像表现/征象

  • 可切除期脑转移独立预测影像因素为无空气支气管征/空泡透亮影(25例中23例)和存在毛刺(25例中15例)。
  • 可切除期N2期患者25例中13例发生脑转移。
  • 不可切除期独立预测因素包括年轻、女性、胸外转移和腺癌。

诊断标准与关键数值

  • 可切除期联合两个影像特征(无空气支气管征/空泡透亮影和毛刺)的模型AUC为0.723。
  • 不可切除期联合临床因素模型的AUC为0.675-0.766。
  • 已知EGFR突变状态亚组中,联合胸外转移和EGFR突变阳性模型的AUC为0.641-0.732。

临床应用与阅片要点

  • 阅片时可关注可切除期NSCLC是否存在空气支气管征/空泡透亮影及毛刺征,结合N2分期提示脑转移风险。
  • 不可切除期患者若为年轻女性、腺癌伴胸外转移,应警惕脑转移可能。

局限性

  • 单中心队列研究,结论外推需谨慎。
  • EGFR突变状态亚组分析仅纳入部分已知突变状态的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To identify clinical and staging chest CT characteristics predictive of brain metastasis in patients with newly diagnosed NSCLC dichotomized according to resectability.

METHODS: Patients newly diagnosed with NSCLC of clinical stages II-IV between November 2017 and October 2018 were enrolled and classified into resectable (stage II+IIIA) and unresectable stages (stage IIIB/C+IV) according to chest CT. Associations of clinicopathological characteristics and CT findings with brain metastasis were analyzed using logistic regression. Predictive models were evaluated using receiver operating characteristics curve analysis. A subgroup analysis for unresectable-stage patients with known epidermal growth factor receptor gene (EGFR) mutation status was performed.

RESULTS: This study included 911 NSCLC patients (mean age, 65 ± 11 years; 620 men), 194 of whom were diagnosed with brain metastasis. For resectable stages, independent predictors for brain metastasis were N2-stage (13 of 25 patients), absence of air-bronchogram/bubble lucency (23 of 25 patients), and presence of spiculation (15 of 25 patients), with a model combining the two imaging features showing an AUC of 0.723. In unresectable stages, independent predictors of brain metastasis were younger age, female sex, extrathoracic metastasis, and adenocarcinoma, with models combining these showing AUCs of 0.675-0.766. In the subgroup with known EGFR-mutation status, extrathoracic metastasis and positive EGFR mutation were independent predictors of brain metastasis, with the model showing AUCs of 0.641-0.732.

CONCLUSION: CT-derived imaging features, clinical stages, lung cancer subtype, and EGFR mutation were associated with brain metastasis in patients with newly diagnosed NSCLC. The predictors were completely different between resectable and unresectable stages.

KEY POINTS: • In resectable stages of NSCLC, two imaging features (absence of air-bronchogram/bubble lucency and presence of spiculation) and N2 stage were independent predictors of brain metastasis. • In unresectable stages of NSCLC, younger age, female sex, extrathoracic metastasis, and adenocarcinoma were associated with brain metastasis. • In the subgroup of NSCLC with known EGFR-mutation status, extrathoracic metastasis and positive EGFR mutation were independent predictors of brain metastasis.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Park S, Lee SM, Ahn Y, et al. Identification of predictors for brain metastasis in newly diagnosed non-small cell lung cancer: a single-center cohort study. Eur Radiol. 2021. PMID: 34378076. doi:10.1007/s00330-021-08215-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。